How should the nicardipine infusion be titrated when a 10 mg/10 mL vial is diluted in 90 mL of normal saline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nicardipine Drip Preparation and Titration

When diluting a 10 mg/10 mL nicardipine vial with 90 mL of normal saline, you create a 100 mL solution at a concentration of 0.1 mg/mL (10 mg in 100 mL total volume), which is the standard concentration recommended by FDA labeling and multiple clinical guidelines.

Concentration Calculation

Your preparation yields:

  • Final concentration: 0.1 mg/mL (10 mg ÷ 100 mL total volume)
  • Final volume: 100 mL

This matches the FDA-approved premixed concentration 1.

Standard Titration Protocol

Initial Dosing

Start at 5 mg/hr as the initial infusion rate 2, 3, 4, 1. This is the universally recommended starting dose across all major guidelines (AHA/ASA Stroke Guidelines, ACC/AHA Hypertension Guidelines, and FDA labeling).

At 0.1 mg/mL concentration:

  • 5 mg/hr = 50 mL/hr pump rate

Titration Schedule

For gradual blood pressure reduction (most common scenario):

  • Increase by 2.5 mg/hr every 15 minutes until target BP achieved 2, 3, 1
  • At 0.1 mg/mL: increase by 25 mL/hr every 15 minutes
  • Maximum dose: 15 mg/hr (150 mL/hr at your concentration) 2, 3, 4, 1

For rapid blood pressure reduction (hypertensive emergencies):

  • Increase by 2.5 mg/hr every 5 minutes 2, 1
  • At 0.1 mg/mL: increase by 25 mL/hr every 5 minutes
  • Maximum remains 15 mg/hr

Maintenance Dosing

Once target BP is achieved, reduce to 3 mg/hr (30 mL/hr) and titrate in small increments (1-2.5 mg/hr) to maintain BP control 5, 1. Research demonstrates sustained BP control is achievable with minimal dose adjustments during maintenance, typically requiring only 3-5 mg/hr 6, 7.

Clinical Context-Specific Targets

Acute Ischemic Stroke (NOT eligible for thrombolytics)

  • Indication: SBP >220 mmHg OR DBP 121-140 mmHg
  • Target: 10-15% BP reduction 2, 3, 2
  • Use standard titration (2.5 mg/hr every 5-15 minutes)

Acute Ischemic Stroke (Eligible for/receiving thrombolytics)

  • Pre-treatment target: SBP <185 mmHg AND DBP <110 mmHg 3, 8, 5
  • During/post-treatment target: SBP <180 mmHg AND DBP <105 mmHg 8, 5
  • Titrate every 5-15 minutes by 2.5 mg/hr 3, 8

Hypertensive Emergency (General)

  • Target: Reduce SBP by no more than 25% in first hour, then to 160/100 mmHg over next 2-6 hours 4
  • Titrate every 5 minutes for rapid control 4, 9

Critical Safety Considerations

Monitor blood pressure continuously or every 5-15 minutes during titration 2, 8, 1. The 2021 AHA Stroke Statement emphasizes close monitoring to avoid excessive BP reduction that could worsen cerebral perfusion 8.

Change peripheral IV site every 12 hours to prevent phlebitis 1. Research shows phlebitis typically occurs after 14+ hours at a single site 10. Consider central line for prolonged infusions.

Expect modest heart rate increase (approximately 5-10 bpm) 6, 10. This reflex tachycardia is generally well-tolerated but monitor for rates >100 bpm, which occurred in 15% of patients in one study 6.

Hypotension management: If BP drops excessively, stop infusion immediately. When stabilized, restart at low dose (3 mg/hr = 30 mL/hr) and re-titrate slowly 1.

Practical Pump Programming

For your 0.1 mg/mL concentration:

Dose (mg/hr) Pump Rate (mL/hr)
3 mg/hr 30 mL/hr
5 mg/hr 50 mL/hr
7.5 mg/hr 75 mL/hr
10 mg/hr 100 mL/hr
12.5 mg/hr 125 mL/hr
15 mg/hr 150 mL/hr

Onset of action is rapid (5-15 minutes), with approximately 50% of maximum effect achieved within 45 minutes of constant infusion 2, 1, 10. Offset occurs within 30 minutes after discontinuation 1, 10.

Compatibility Warning

Do not mix with sodium bicarbonate or lactated Ringer's solution 1. Compatible with D5W, normal saline, D5W with 0.45% or 0.9% NaCl, and D5W with 40 mEq potassium 1.

References

Research

Intravenous nicardipine for the treatment of severe hypertension.

The American journal of medicine, 1988

Related Questions

What is the recommended dosage and titration protocol for a continuous intravenous nicardipine infusion?
What is the maximum rate for a nicardipine infusion in cc per hour?
If 25 mg of nicardipine is diluted in 240 mL of intravenous fluid, what infusion rate in milliliters per hour will deliver 5 mg per hour?
How should I titrate a nicardipine infusion when the 10 mg/mL vial is diluted with 90 mL sterile water?
How do I calculate the infusion rate (mL/hour) for an adult nicardipine drip when targeting 5 mg per hour using a preparation of 50 mg nicardipine in 250 mL D5W?
What is the likely cause and recommended management for acute psychosis after abruptly stopping alcohol and the benzodiazepine Ativan (lorazepam) while taking levetiracetam (Keppra)?
What is the significance of white-appearing capillaries and veins on a sagittal T2-weighted fat-saturated ankle MRI?
What is the recommended management and follow-up for birdshot chorioretinopathy?
What is the appropriate management for a 5-year-old child with mild xerosis on the buttock and cheek that improves with moisturizers but worsens after discontinuation?
Regarding tinnitus, which of the following statements are correct: A) It does not necessarily have to be accompanied by hearing loss; B) It can affect sleep and daily functioning; C) A pulsatile sensation indicates a benign condition; D) Initial investigation includes audiometry and MRI in cases of unilateral vertigo?
How does bupropion interact with warfarin (Jantoven) and what monitoring is required when co‑prescribing them?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.